HEPATITIS C

 

HEPATITIS C

 

DEFINITION:

An infectious disease of the liver caused by the hepatitis C virus (HCV) resulting in a chronic hepatitis.

EPIDEMIOLOGY:

  • incidence: may cause 20-40% of all acute hepatitis cases
  • age of onset:
    • ?
  • risk factors:
    • endemic (worldwide with an estimated 100 million HCV carriers)
    • transfusion recipients, IV drug users, hemodialysis patients, health care workers with frequent blood contact

PATHOGENESIS:

1. Etiology

1. Hepatitis C Virus

  • a single-stranded RNA flavivirus <80 nm in diameter
  • the genome has been cloned
  • routes of infection:
    • usually parenteral
    • occasionally through intimate sexual contact

2. Hepatitis C

  • previously called "parenterally-transmitted non-A, non-B hepatitis"
  • causes sporadic or posttransfusion hepatitis

2. Pathogenesis

  • infection -> 1-5 month incubation period -> noncytopathogenic injury to hepatocytes but hepatocellular necrosis due to the cellular and immune response of the host to HCV infection
  • acute hepatitis represents an effective immune response which is able to eliminate the virus-infected cells
  • chronic hepatitis - represents an ineffective immune response which is unable to totally eliminate the virus-infected cells

CLINICAL FEATURES:

1. Prodrome

  • arthritis and rash may be present

2. Hepatitis

  • insidious onset with duration of illness ranging from several weeks to months
  • while the preicteric phase can last up to 5 days, the icteric phase lasts from days to months with a mean of 8-11 days in children
  • generally the signs/symptoms of the acute illness are milder than with HAV and HBV infections

1. Preicteric Phase

1. Fever

  • may be absent in children but last up to 5 days in adolescents
  • ranges from 37.8-40 C

2. Accompanying Signs/Symptoms

  • abdominal pain
  • anorexia
  • headache
  • lethargy
  • nausea/vomiting
  • hepatomegaly (tender)
  • lymphadenopathy
  • splenomegaly

2. Icteric Phase

1. Jaundice

  • most patients with HCV infection are anicteric
  • transition to the icteric phase is marked by the disappearance of preicteric signs/symptoms in young children but the exacerbation of these signs/symptoms in older children and adolescents

3. Hepatic Complications

1. Chronic Persistent Hepatitis

  • a pathological diagnosis based on finding an inflammatory process on liver biopsy involving only the portal areas - anicteric and asymptomatic except for mild hepatomegaly
  • - moderate elevation of ALT
  • lasts longer than 6 months and may resolve after years or progress to chronic active hepatitis

2. Chronic Active Hepatitis

  • chronic and recurrent episodes of jaundice and elevated
  • ALT and AST
  • may progress to cirrhosis +/- portal hypertension with ascites

3. Liver Failure

1. Fulminant Hepatitis

  • liver failure occurring within days to 4 weeks after the onset of acute hepatitis
  • associated with mental confusion, emotional instability, restlessness, bleeding, and coma

2. Subacute Hepatitis

  • liver failure occurring 1-3 months after the onset of acute hepatitis

4. Hepatocellular Carcinoma

  • those with anti-HCV, have a 25x higher risk than the normal population of developing hepatocellular cancer

INVESTIGATIONS:

1. Serum

1. Alanine Aminotransferase (ALT)

  • striking rise in level after the incubation period and levels fluctuate over a prolonged period of time

2. Bilirubin

  • transient elevation associated with the peak in ALT levels lasting up to 2 months

3. Serology

  • the mean interval from onset of hepatitis to detection of anti-HCV may be as long as 15 weeks (range 4-32 weeks) which then disappears in those with acute disease or persists in those with chronic disease

4. Viremia

  • HCV-RNA can be detected 2 weeks after a transfusion of HCV-contaminated blood and will persist in those with chronic hepatitis

MANAGEMENT:

1. Supportive

  • symptomatic

2. Medical

  • alpha-interferon (6th month course) is effective in 5-25% of patients

3. Prognosis

  • can result in chronic hepatitis, liver disease, and/or a carrier state (yet there is a very low risk of perinatal infections)
  • there is a relatively high incidence (about 50%) of chronic liver diseae
  • mortality from fulminant hepatitis is:
    • 1-2% in uncomplicated cases
    • 2% in complicated cases

 

 

Pediatric Database - HEPATITIS C

Pediatric Organization - Pedbase [at] Gmail.com